Dispensed prescriptions of hydroxychloroquine in the U.S. increased 86.2%, while such prescriptions of chloroquine increased 158.6% from February to March 2020, data show.
The report in JAMA Internal Medicine also showed that the percentage of patients receiving both hydroxychloroquine and azithromycin prescriptions increased 1,044% during the same time period.
Nadine Shehab, PharmD, MPH, of the CDC’s COVID-19 Response Team, and colleagues used information from the IQVIA Total Patient Tracker, a database that compiles initial prescriptions and refills paid for by commercial third parties,
Uncategorized